We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$1.3B
AUM Growth
+$93.3M
Cap. Flow
-$7.51M
Cap. Flow %
-0.58%
Top 10 Hldgs %
25.17%
Holding
390
New
85
Increased
121
Reduced
146
Closed
8

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.53M
2
DOCU
DocuSign
DOCU
+$1.16M
3
AAPL icon
Apple
AAPL
+$971K
4
MZTI
The Marzetti Company
MZTI
+$858K
5
MSFT icon
Microsoft
MSFT
+$723K

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.98%
2 Technology 14.73%
3 Healthcare 13.63%
4 Financials 11.39%
5 Consumer Staples 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LDOS icon
101
Leidos
LDOS
$17.7B
$3.76M 0.29%
38,414
VEA icon
102
Vanguard FTSE Developed Markets ETF
VEA
$238B
$3.71M 0.28%
84,174
-540
-0.6% -$23K
VSS icon
103
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12.1B
$3.64M 0.28%
32,770
-303
-0.9% -$32.3K
CL icon
104
Colgate-Palmolive
CL
$72.3B
$3.6M 0.28%
52,375
-766
-1% -$52.2K
VHT icon
105
Vanguard Health Care ETF
VHT
$19.3B
$3.57M 0.27%
18,606
-250
-1% -$44.8K
ITW icon
106
Illinois Tool Works
ITW
$79.8B
$3.51M 0.27%
19,563
+138
+0.7% +$23.4K
MDT icon
107
Medtronic
MDT
$117B
$3.51M 0.27%
30,951
+964
+3% +$106K
CATH icon
108
Global X S&P 500 Catholic Values ETF
CATH
$1.35B
$3.49M 0.27%
88,420
VWO icon
109
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$3.37M 0.26%
75,698
+1,070
+1% +$45.3K
NOC icon
110
Northrop Grumman
NOC
$77.5B
$3.22M 0.25%
9,371
-542
-5% -$191K
BLK icon
111
Blackrock
BLK
$180B
$3.22M 0.25%
6,404
+43
+0.7% +$20.4K
IVV icon
112
iShares Core S&P 500 ETF
IVV
$898B
$3.11M 0.24%
9,635
-547
-5% -$169K
YUM icon
113
Yum! Brands
YUM
$42B
$3.09M 0.24%
30,632
-434
-1% -$45K
BNY
114
Bank of New York Mellon
BNY
$110B
$3.07M 0.24%
61,064
+268
+0.4% +$12.8K
VBR icon
115
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.6B
$3M 0.23%
21,908
+223
+1% +$29.5K
BKNG icon
116
Booking.com
BKNG
$155B
$2.99M 0.23%
36,350
+675
+2% +$53K
EMB icon
117
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$2.97M 0.23%
25,946
+128
+0.5% +$14.5K
NFLX icon
118
Netflix
NFLX
$340B
$2.95M 0.23%
91,160
+3,210
+4% +$95.2K
GILD icon
119
Gilead Sciences
GILD
$181B
$2.93M 0.22%
45,092
-2,470
-5% -$161K
TJX icon
120
TJX Companies
TJX
$149B
$2.91M 0.22%
47,615
+1,597
+3% +$94.4K
WBA
121
DELISTED
Walgreens Boots Alliance
WBA
$2.86M 0.22%
48,499
-243
-0.5% -$14K
AMAT icon
122
Applied Materials
AMAT
$366B
$2.85M 0.22%
46,708
+1,962
+4% +$110K
EMR icon
123
Emerson Electric
EMR
$86.6B
$2.83M 0.22%
37,068
-300
-0.8% -$21.6K
KMB icon
124
Kimberly-Clark
KMB
$36.4B
$2.81M 0.22%
20,389
+285
+1% +$38.5K
MET icon
125
MetLife
MET
$61.3B
$2.74M 0.21%
53,841
+1,629
+3% +$78.6K

Similar funds

Dowling & Yahnke's Q4 2019 Portfolio in Review

As of Q4 2019, Dowling & Yahnke held 390 positions worth $1.3B, up 7.7% from $1.21B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Dowling & Yahnke's Q4 2019 filing shows 85 new, 121 increased, 146 reduced and 8 closed positions. Its largest new stake was iShares National Muni Bond ETF: 4,701 shares worth $535K. The largest sale was Celgene Corp, an estimated $2.53M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.

  • Dowling & Yahnke's largest Q4 2019 buy was iShares National Muni Bond ETF: 4,701 shares worth $535K.
  • Dowling & Yahnke added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.6M increase.
  • Dowling & Yahnke's biggest Q4 2019 reduction was DocuSign, cutting an estimated $1.16M.
  • Dowling & Yahnke fully exited Celgene Corp in Q4 2019, selling an estimated $2.53M.
  • Dowling & Yahnke's ten largest holdings make up 25% of its $1.3B portfolio in Q4 2019.
  • Dowling & Yahnke opened 85 new positions and closed 8 in Q4 2019.
  • Dowling & Yahnke's portfolio value rose 7.7% quarter-over-quarter to $1.3B.

Based on Dowling & Yahnke's 13F filing for Q4 2019, filed 27 Jan 2020.